Clinical trial
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy
NCT07507422 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy
- Lead sponsor
- Medtronic
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 17, 2026
- Completion date
- January 11, 2034
- Enrollment
- 970 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.